OVARIAN CANCER and US: Oncolytic biotech

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label Oncolytic biotech. Show all posts
Showing posts with label Oncolytic biotech. Show all posts

Monday, September 13, 2010

media: Novel Study Using Reoviruses Against Ovarian Cancer Pushes Forward



Calgary-based Oncolytics Biotech Inc. recently announced that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN® in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).